TICKERNERD
Menu
CMECMEFinancial Services · Financial Data & Stock Exchanges

CME Stock Forecast: CME Group, Inc. Price Predictions for 2026-2027

Last close, 2 Oct 2026
$263
−0.78% on the day

The 17 Wall Street analysts covering CME Group, Inc. hold a median 12-month price target of $286 — +8.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 63 of 100 as at 3 Oct 2026 — in the upper half.

Market cap
$94.6B
Ticker Nerd rank
63 / 100
Median analyst target
$286
Analysts covering
17
Revenue$1.7B+0.8% y/y
Operating income$1.1B
Net income$1.0B
Free cash flow$923.5M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−0.5%
1M
−4.8%
YTD
−0.4%
1Y
+2.9%
From 52W high
−16.7%
From 52W low
+20.9%
$218
$316
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CME stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores CME Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 3 Oct 2026
63 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
95
Quality
81
Value
70
Issuance
67
Revisions
66
Momentum
63
Growth
58
Accruals
23
Size
3

Volatility (95): The share price has been relatively steady.

Accruals (23): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (3): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CME stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CME, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$220$240$260$280$300$320$340Jan 26Apr 26Jul 26Oct 26CMEHigh $330Median $286Low $217

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says17 analysts
9 Buy5 Hold3 Sell
Low $217Median $286High $330

The green dot is the last close — the median target sits +8.5% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 3 moved their price target up and 5 moved it down.

DateFirmActionRatingTarget
2 Oct 2026Wells FargoInitiatesOverweight$301
28 Sept 2026TD CowenReiteratesBuy$292
3 Sept 2026TD CowenReiteratesBuy$292
3 Sept 2026TD CowenReiteratesBuy—
19 Aug 2026Deutsche BankDowngradeHold$286 → $270
19 Aug 2026Deutsche BankDowngradeHold—
23 July 2026B of A SecuritiesMaintainsUnderperform$226 → $230
23 July 2026B of A SecuritiesMaintainsUnderperform—
23 July 2026JP MorganMaintainsUnderweight$249 → $250
23 July 2026JP MorganMaintainsUnderweight—
23 July 2026Morgan StanleyMaintainsOverweight—
23 July 2026Morgan StanleyMaintainsOverweight$324 → $330
15 July 2026Piper SandlerMaintainsOverweight$329 → $295
15 July 2026Piper SandlerMaintainsOverweight—
10 July 2026Morgan StanleyMaintainsOverweight$353 → $324
10 July 2026Morgan StanleyMaintainsOverweight—
9 July 2026BarclaysMaintainsEqual-Weight$316 → $270
9 July 2026BarclaysMaintainsEqual-Weight—
8 July 2026TD CowenMaintainsBuy$273 → $270
8 July 2026TD CowenMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CME appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

CME vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 2 Oct 2026, CME Group, Inc. returned +2.9% against +16.2% for the S&P 500, dividends included.

CME vs S&P 500, last 12 monthsTotal return, rebased to 100
8090100110120Jan 26Apr 26Jul 26Oct 26CMES&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CME analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−0.2%
Analysts raising
2
Analysts cutting
2
Fundamentals

CME Group, Inc. (CME) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
22.3×

Cheaper than 33% of US stocks

Price / sales
14.0×

Cheaper than 12% of US stocks

Price / book
3.6×

Cheaper than 28% of US stocks

EV / EBITDA
20.2×

Cheaper than 15% of US stocks

Growth & margins
Revenue growth (YoY)
0.8%

Higher than 29% of US stocks

Earnings growth (YoY)
1.6%

Higher than 38% of US stocks

Gross margin
86.3%

Higher than 95% of US stocks

Operating margin
65.0%

Higher than 99% of US stocks

Net margin
63.4%

Higher than 97% of US stocks

Returns & dividend
Return on equity
15.8%

Higher than 75% of US stocks

Return on assets
1.5%

Higher than 55% of US stocks

Dividend yield
2.0%

Higher than 43% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

CME Group, Inc. (CME) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • CME Group, Inc. has a market value of $94.6B and an enterprise value of $96.2B.

  • Revenue in the twelve months to 30 June 2026: $6.8B. The latest quarter grew 0.8% year on year.

  • Net income over the same four quarters: $4.3B, a 63.3% net margin.

  • Diluted earnings per share, trailing twelve months: $11.79.

  • Free cash flow in the twelve months to 30 June 2026: $4.2B.

  • CME Group, Inc. spent $1.5B on share buybacks and $4.1B on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 359,275.

  • Trailing P/E: 22.3×; forward P/E: 20.3× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 1.98%, paying out 95% of earnings.

  • CME Group, Inc. employs 3,875 people — $1.7M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 3 Oct 2026

Data provided by Twelve Data

Peers

CME vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelFinancial Data & Stock Exchanges
CompanyMarket capTKN rank
CMECME Group, Inc.$94.6B
63
ICEIntercontinental Exchange, Inc.$85.6B
65
SPGIS&P Global, Inc.$113.9B
46
MCOMoody's Corp.$78.7B
72
NDAQNasdaq, Inc.$51.6B
97
COINCoinbase Global, Inc.$49.4B
4
MSCIMSCI, Inc.$39.4B
61

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own CME Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CME news & analysis

CME vs. Robinhood Markets: Which Financial Stock Is a Better Buy in 2026?

The Motley Fool · 29 Sept 2026neutral

The Motley Fool compares CME Group and Robinhood Markets as financial stock investments for 2026. The article notes CME's dominance in the global derivatives market with exceptional profitability and high net margins, while Robinhood expands its retail ecosystem through crypto and prediction markets.

Why it matters — The comparison highlights CME's market position and profitability, which CME watchers would find relevant when assessing its competitive standing against a retail-focused rival.

Where I'd Put My Next $10,000 In Stocks

Seeking Alpha · 29 Sept 2026neutral

A Seeking Alpha article discusses where to allocate $10,000 in stocks, favoring hyperscalers like Amazon and Alphabet over their suppliers due to AI buildout bottlenecks, while also highlighting contrarian value in high-quality cyclical stocks and select REITs such as Getty Realty as rate-driven pressures may create rebound opportunities.

Why it matters — CME watchers may be interested in the article's discussion of rate conditions and market pressures, which are relevant to trading and derivatives activity.

BitMEX Has Shut Down: Where Do Its Traders Go Now?

24/7 Wall Street · 23 Sept 2026neutral

BitMEX, the exchange that popularized cryptocurrency's perpetual swap contracts, has ceased operations after 11 years, leaving its remaining customers to find new trading platforms.

Why it matters — The closure of a prominent crypto derivatives exchange may shift trading volume and attention toward other venues, including CME, whose own crypto derivatives offerings could be affected.

CME Group Expands Equity Derivatives With New Factor Futures

Zacks Investment Research · 22 Sept 2026positive

CME Group is expanding its equity derivatives lineup with new factor futures, designed to offer targeted exposure, margin offsets, and flexible trading for institutional clients. The move broadens CME's product range in the equity derivatives space.

Why it matters — A CME watcher would care because introducing new factor futures expands CME's product portfolio and could deepen institutional engagement in its equity derivatives offerings.

FAQ

Frequently asked questions about CME stock

What is the CME stock price forecast for 2026-2027?

The 17 Wall Street analysts covering CME Group, Inc. have a median 12-month price target of $286, with estimates ranging from $217 to $330. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CME stock a buy right now?

Of the 17 analysts covering CME Group, Inc., 9 rate it a Buy, 5 a Hold and 3 a Sell. Ticker Nerd's systematic factor model ranks CME Group, Inc. 63 out of 100 across roughly 4,600 US stocks as at 3 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CME?

As at 3 Oct 2026, CME Group, Inc. ranks 63 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (95 of 100).

Will CME stock go up?

No one can know that. What the data says: the median 12-month target from 17 analysts implies +8.5% from the last close, and Ticker Nerd's factor model ranks CME Group, Inc. 63 out of 100 as at 3 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CME stock forecast for 2030?

No analyst covering CME Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CME are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $217 to $330 over the next 12 months.

How has CME stock performed over the past year?

CME Group, Inc. returned +2.9% over the 12 months to 2 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does CME Group, Inc. do?

CME Group Inc. Class A Common Stock represents ownership in CME Group, a leading global marketplace for derivatives trading and market data services.

What is the latest news on CME?

The most recent item we track (The Motley Fool, 29 Sept 2026): "CME vs. Robinhood Markets: Which Financial Stock Is a Better Buy in 2026?". The Motley Fool compares CME Group and Robinhood Markets as financial stock investments for 2026. The article notes CME's dominance in the global derivatives market with exceptional profitability and high net margins, while Robinhood expands its retail ecosystem through crypto and prediction markets.

Company

About CME Group, Inc.

CME Group Inc. Class A Common Stock represents ownership in CME Group, a leading global marketplace for derivatives trading and market data services. CME Group operates a broad range of futures and options contracts across major asset classes, including interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals. Its core businesses also include clearing, settlement, and related market infrastructure that support risk management and price discovery for institutional investors, commercial hedgers, brokers, and other market participants. The company’s exchange and clearing services are widely used by financial firms and corporate users seeking efficient access to standardized, centrally cleared contracts. CME Group Inc. is headquartered in Chicago and is known for its diversified role in global financial markets, where its products help facilitate trading, hedging, and liquidity across multiple asset classes.

CEO Mr. Terrence A. Duffy · 3,875 employees · United States · https://www.cmegroup.com